February 5, 2025

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end

Perforator Yandex introduces Perforator, a tool that can identify and evaluate code inefficiencies across a company’s entire code base. Perforator helps developers identify the most resource-intensive sections of code and provides detailed statistics for subsequent optimization. The solution can help businesses reduce CPU resource usage by 20% annually. By leveraging

Perforator Yandex présente Perforator, un outil capable d’identifier et d’évaluer les inefficacités du code dans l’ensemble de la base de code d’une entreprise. Perforator aide les développeurs à identifier les sections de code les plus gourmandes en ressources et fournit des statistiques détaillées pour une optimisation ultérieure. Le Cette solution

La plateforme LM4 permet l’automatisation de la gestion à un coût abordable pour les répartiteurs intermédiaires (IDF) et les sites de petite taille IRVINE, Californie, 05 févr. 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ : LTRX), un leader mondial du calcul et de la connectivité pour les solutions IoT permettant

Report finds that internet users have passed the 5.5 billion mark, with 136 million new users added in the last 12 months SAN FRANCISCO, Feb. 05, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, and We Are Social, the socially-led creative agency, have released